KLACID

This brand name is authorized in Austria, Australia, Germany, Estonia, Spain, Finland, Hong Kong, Ireland, Israel, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug KLACID contains one active pharmaceutical ingredient (API):

1 Clarithromycin UNII H1250JIK0A - CLARITHROMYCIN

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. Read about Clarithromycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KLACID Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA09	Clarithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8318T, 9192T
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00557576, 00776798, 01449133, 03873148, 03873154
Country: EE	Ravimiamet	Identifier(s): 1032736, 1032747, 1032758, 1044177, 1068881, 1068904, 1405460, 1405471, 1405482, 1405493, 1405505, 1405516, 1405527, 1405538
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60202, 60515, 60518, 63380
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 134338, 135079, 494146, 582833
Country: HK	Department of Health Drug Office	Identifier(s): 35866, 36468, 38143, 38306, 42378, 43890, 48787, 59109
Country: IE	Health Products Regulatory Authority	Identifier(s): 16675, 30079, 31603, 31714, 32000, 32064, 32065, 92029, 92037, 92207
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2761
Country: IT	Agenzia del Farmaco	Identifier(s): 027370055, 027370067, 027370117, 027370129, 027370143
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003065, 1003066, 1003067, 1003068, 1003316, 1009157, 1036969, 1060307, 1060308, 1060309, 1060310, 1060311, 1060312, 1060313, 1079071, 1081427, 1081951, 1090126, 1090127
Country: MT	Medicines Authority	Identifier(s): MA1507/01301, MA1507/01302, MA1507/01303, MA1507/01304, MA1507/01305, MA1507/01306, PI1438/02301A, PI1438/02302A, PI908/06402A, PI908/06405A
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 49425
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6457, 6458, 6459, 6460, 6464
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100033462, 100033479, 100075673, 100082294, 100082928, 100084873, 100332963, 100335890, 100370372, 100383370, 100419894, 100437136, 100451711, 100456970, 100463529
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68967001, W68967002, W68968001, W68969001, W68969002, W68970001, W68970002, W68970003
Country: SG	Health Sciences Authority	Identifier(s): 07085P, 09119P, 09193P, 09354P, 09884P, 11387P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699548030802, 8699548030864, 8699548031601, 8699548090479, 8699548270482, 8699548280283, 8699548280511, 8699548281112
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/20.1.1/0035, 31/20.1.1/0379